IL129187A0 - NMDA (N-methyl-D-aspartate) antagonists - Google Patents

NMDA (N-methyl-D-aspartate) antagonists

Info

Publication number
IL129187A0
IL129187A0 IL12918797A IL12918797A IL129187A0 IL 129187 A0 IL129187 A0 IL 129187A0 IL 12918797 A IL12918797 A IL 12918797A IL 12918797 A IL12918797 A IL 12918797A IL 129187 A0 IL129187 A0 IL 129187A0
Authority
IL
Israel
Prior art keywords
nmda
aspartate
antagonists
methyl
Prior art date
Application number
IL12918797A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of IL129187A0 publication Critical patent/IL129187A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12918797A 1996-09-30 1997-08-18 NMDA (N-methyl-D-aspartate) antagonists IL129187A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72317596A 1996-09-30 1996-09-30
PCT/US1997/014486 WO1998014427A1 (en) 1996-09-30 1997-08-18 Nmda (n-methyl-d-aspartate) antagonists

Publications (1)

Publication Number Publication Date
IL129187A0 true IL129187A0 (en) 2000-02-17

Family

ID=24905175

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12918797A IL129187A0 (en) 1996-09-30 1997-08-18 NMDA (N-methyl-D-aspartate) antagonists

Country Status (18)

Country Link
EP (1) EP0929521B1 (de)
JP (1) JP2001501221A (de)
KR (1) KR20000048715A (de)
CN (1) CN1139572C (de)
AR (1) AR009374A1 (de)
AT (1) ATE309215T1 (de)
AU (1) AU732997B2 (de)
BR (1) BR9712144A (de)
CA (1) CA2266556C (de)
DE (1) DE69734594T2 (de)
DK (1) DK0929521T3 (de)
HU (1) HUP0000882A3 (de)
IL (1) IL129187A0 (de)
NO (1) NO314080B1 (de)
NZ (1) NZ334343A (de)
TW (1) TW492958B (de)
WO (1) WO1998014427A1 (de)
ZA (1) ZA978602B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010053849A1 (en) * 1999-06-16 2001-12-20 Mary Jeanne Kreek Plural biological sample arrays, and preparation and uses thereof
KR20030060771A (ko) 2000-04-28 2003-07-16 메모리얼 슬로안-케터링 캔서 센터 국소용 마취제/아편양약물 제제 및 이들의 용도
HU227197B1 (en) 2000-10-24 2010-10-28 Richter Gedeon Nyrt Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
AU2008315651B2 (en) * 2007-10-22 2012-12-13 Orchid Research Laboratories Limited Histone deacetylase inhibitors
KR20120123089A (ko) 2010-02-16 2012-11-07 화이자 인코포레이티드 5-ＨＴ₄ 수용체의 부분 효능제인 (Ｒ)-4-((4-((4-(테트라히드로푸란-3-일옥시)벤조［ｄ］이속사졸-3-일옥시)메틸)피페리딘-1-일)메틸)테트라히드로-2Ｈ-피란-4-올
CA3146163A1 (en) 2019-07-08 2021-01-14 University Of Health Sciences & Pharmacy In St. Louis G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment
CN121695288A (zh) 2020-02-19 2026-03-20 Epizyme股份有限公司 Setd2抑制剂和相关方法和用途，包括组合疗法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU216787B (hu) * 1990-07-16 1999-08-30 Merrell Dow Pharmaceuticals Inc. Eljárás excitátoros aminosav-antagonista hatású indolszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
WO1994027964A1 (en) * 1993-05-27 1994-12-08 Merrell Dow Pharmaceuticals Inc. 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
GB9319243D0 (en) * 1993-09-17 1993-11-03 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
AU732997B2 (en) 2001-05-03
EP0929521B1 (de) 2005-11-09
TW492958B (en) 2002-07-01
CA2266556A1 (en) 1998-04-09
EP0929521A1 (de) 1999-07-21
AR009374A1 (es) 2000-04-12
WO1998014427A1 (en) 1998-04-09
AU4071897A (en) 1998-04-24
HUP0000882A3 (en) 2001-04-28
NO991533D0 (no) 1999-03-29
DK0929521T3 (da) 2006-03-27
ATE309215T1 (de) 2005-11-15
ZA978602B (en) 1998-03-30
NO991533L (no) 1999-05-28
NO314080B1 (no) 2003-01-27
DE69734594D1 (en) 2005-12-15
CN1139572C (zh) 2004-02-25
NZ334343A (en) 2001-01-26
HUP0000882A2 (hu) 2000-09-28
CN1232452A (zh) 1999-10-20
CA2266556C (en) 2007-11-06
JP2001501221A (ja) 2001-01-30
KR20000048715A (ko) 2000-07-25
BR9712144A (pt) 1999-08-31
DE69734594T2 (de) 2006-07-06

Similar Documents

Publication Publication Date Title
IL133235A0 (en) 1-Amino-alkylcyclohexane nmda receptor antagonists
HU9603082D0 (en) Neurokinine (tachykinine) antagonists
EG23913A (en) Estrogen agonists / antagonists
HUT74808A (en) Gnrh antagonists
HU9601176D0 (en) Adhesion-receptor antagonists
FI971026A7 (fi) Kinoksaliinidioni-NMDA-reseptoriantagonisteja
AP9801212A0 (en) Tetrahydroquin olinesas NMDA antagonists
SG66425A1 (en) Improved vibrator-driven table apparatus
DE69734594D1 (en) Nmda (n-methyl-d-aspartate) antagonists
TW371533U (en) Adapter
GB9610099D0 (en) An adapter
TW342596U (en) Suspension-positioning fowl-raising apparatus addition (I)
GB9820008D0 (en) Sorting apparatus
GR3015656T3 (en) NMDA antagonists.
GB9710166D0 (en) Device
HK1018954A (en) Nmda (n-methyl-d-aspartate) antagonists
IL122005A0 (en) Adapter
NZ314277A (en) Octopeptide somatostatin antagonist
GB9719843D0 (en) Intergrin antagonists
GB9725996D0 (en) Intergrin antagonists
TW370290U (en) Adapter set
GB9716451D0 (en) Projection apparatus
GB9706767D0 (en) PC2000 tester
ZA988386B (en) Sorting apparatus
TW338573U (en) An adapter

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees